Publications by authors named "Mariateresa Fulciniti"

60Publications

The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma.

Leukemia 2020 01 10;34(1):167-179. Epub 2019 Jun 10.

Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0498-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901818PMC
January 2020

Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma.

Cell Rep 2018 12;25(13):3693-3705.e6

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; VA Boston Healthcare System, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2018.12.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407615PMC
December 2018

Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14).

Blood 2018 12 14;132(26):2778-2780. Epub 2018 Nov 14.

Unit for Genomics in Myeloma, Institut Universitaire du Cancer-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2018-09-876433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307986PMC
December 2018

Widespread intronic polyadenylation diversifies immune cell transcriptomes.

Nat Commun 2018 04 30;9(1):1716. Epub 2018 Apr 30.

Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-018-04112-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928244PMC
April 2018

Tolerance, Kinetics, and Depth of Response for Subcutaneous Versus Intravenous Administration of Bortezomib Combination in Chinese Patients With Newly Diagnosed Multiple Myeloma.

Clin Lymphoma Myeloma Leuk 2018 06 15;18(6):422-430. Epub 2018 Mar 15.

State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academic Medical Science and Peking Union Medical College, Tianjin, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.03.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5970050PMC
June 2018

Determining therapeutic susceptibility in multiple myeloma by single-cell mass accumulation.

Nat Commun 2017 11 20;8(1):1613. Epub 2017 Nov 20.

Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, 500 Main St., Cambridge, MA, 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41467-017-01593-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694762PMC
November 2017

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.

Mol Cancer Ther 2016 06 18;15(6):1364-75. Epub 2016 May 18.

Department of Experimental and Clinical Medicine, Magna Graecia University and Translational Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0985DOI Listing
June 2016

Biological Insights into Myeloma and Other B Cell Malignancies.

Biomed Res Int 2016 16;2016:5218093. Epub 2016 Feb 16.

Washington University, Saint Louis, MO 63108, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/5218093DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771877PMC
December 2016

Deep Response in Multiple Myeloma: A Critical Review.

Biomed Res Int 2015 10;2015:832049. Epub 2015 Dec 10.

Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of hematology, Hospital 12 de Octubre, Unidad CRIS, CNIO, University of Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/832049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689894PMC
October 2016

Differential and limited expression of mutant alleles in multiple myeloma.

Blood 2014 Nov 18;124(20):3110-7. Epub 2014 Sep 18.

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Hematology/Oncology, Boston Veterans Administration Healthcare System, West Roxbury, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-04-569327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231420PMC
November 2014

Intracellular NAD⁺ depletion enhances bortezomib-induced anti-myeloma activity.

Blood 2013 Aug 3;122(7):1243-55. Epub 2013 Jul 3.

LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-02-483511DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744991PMC
August 2013

Mechanism of action of immunomodulatory agents in multiple myeloma.

Med Oncol 2010 Jun 20;27 Suppl 1:S7-13. Epub 2010 Apr 20.

VA Boston Healthcare System, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12032-010-9527-y
Publisher Site
http://dx.doi.org/10.1007/s12032-010-9527-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155938PMC
June 2010

The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo.

Clin Cancer Res 2009 Jun 9;15(12):4028-37. Epub 2009 Jun 9.

Department of Medical Oncology, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2867DOI Listing
June 2009

Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM).

Blood 2007 Feb 10;109(3):1220-7. Epub 2006 Oct 10.

The Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-04-015149DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1785138PMC
February 2007